BPC-157 vs TB-500
Healing peptide comparison guide
BPC-157 and TB-500 are the two most popular healing peptides in the research and biohacking communities. Both accelerate tissue repair, but they work through fundamentally different mechanisms. BPC-157 focuses on local repair through angiogenesis and growth factor modulation, while TB-500 drives systemic healing via cell migration and inflammation reduction. Understanding the differences helps you choose the right peptide — or decide whether stacking both is the best approach.
At a Glance
BPC-157
Body Protection Compound-157
A 15-amino-acid synthetic peptide derived from human gastric juice. Promotes local tissue repair through angiogenesis, growth factor upregulation, and nitric oxide modulation. Especially effective for gut, tendon, and localized injuries.
TB-500
Thymosin Beta-4 fragment
A 43-amino-acid peptide fragment of Thymosin Beta-4. Promotes systemic healing through actin regulation, cell migration, and broad anti-inflammatory effects. Works throughout the body regardless of injection site.
Side-by-Side Comparison
| Property | BPC-157 | TB-500 |
|---|---|---|
| Mechanism | Angiogenesis, growth factor upregulation, nitric oxide modulation | Cell migration, actin regulation, anti-inflammatory signaling |
| Typical dose | 250–500 mcg/day | 2–5 mg, 2x/week |
| Frequency | Daily | 2x per week |
| Half-life | ~4 hours | ~2–3 days |
| Injection site | Near injury matters — local effects enhanced | Systemic — location doesn't matter |
| Route | Subcutaneous or oral | Subcutaneous or intramuscular only |
| Cost per month | ~$30–60 | ~$40–80 |
| Best for | Gut healing, tendons, localized injuries | Systemic inflammation, muscle, joints |
When to Use Each
Choose BPC-157 when...
- You have a specific, localized injury — a tendon tear, a ligament strain, a muscle pull
- You need gut healing — IBS, leaky gut, NSAID-induced damage, or gastric issues
- You want an oral option — BPC-157 is the only healing peptide with meaningful oral bioavailability
- Budget is a concern — daily dosing is cheaper per month than TB-500
- You want targeted local repair and are willing to inject near the injury site
Choose TB-500 when...
- You have widespread inflammation or multiple injury sites — TB-500 works systemically
- You prefer less frequent injections — only 2x/week vs daily
- You have a large muscle or joint injury where systemic cell migration is beneficial
- Injection location doesn't matter to you — abdomen, deltoid, anywhere works equally
- You want broad anti-inflammatory and anti-fibrotic effects across the whole body
When to Stack Both: The BPC + TB Stack
The BPC-157 + TB-500 combination is the most popular healing peptide stack for good reason — their mechanisms are complementary, not redundant. BPC-157 drives local blood vessel formation and growth factor expression while TB-500 reduces systemic inflammation and promotes cell migration to the injury site.
Ideal stack candidates
- Moderate to severe injuries — post-surgical recovery, significant tendon/ligament tears
- Chronic conditions with both local damage and systemic inflammation
- Athletes or active individuals returning from injury who want maximum recovery speed
- Cases where a single peptide alone has provided partial but incomplete improvement
Recommended stack protocol
Inject subQ near injury site, daily
Inject subQ anywhere, twice weekly
Both peptides can be injected at the same time. Some users draw both into one syringe. They do not interact negatively.
FAQ
Can I take BPC-157 and TB-500 at the same time?
Yes. They work through different mechanisms and are commonly stacked together. BPC-157 is taken daily while TB-500 is taken 2x/week. They can be injected in the same session — some users even draw both into a single syringe.
Which peptide is better for tendon injuries?
BPC-157 has stronger direct evidence for tendon healing in animal studies, especially when injected near the injury site. TB-500 supports tendon repair through its anti-inflammatory and cell migration effects. For significant tendon injuries, stacking both is the most common approach.
Is one safer than the other?
Both have favorable safety profiles in animal studies with no reported organ toxicity at therapeutic doses. Neither has completed FDA-approved human clinical trials. Anecdotally, both are well-tolerated with only mild side effects (injection site redness, occasional nausea).
Can I take either peptide orally?
BPC-157 has meaningful oral bioavailability and is commonly taken orally for gut healing. TB-500 does not have reliable oral bioavailability and must be injected (subcutaneous or intramuscular).
How long does each take to work?
BPC-157 users typically report improvement within 1–2 weeks for acute injuries. TB-500 may take slightly longer (2–3 weeks) due to its less frequent dosing schedule, but its longer half-life provides more sustained effects between doses.
Do I need to cycle off?
Most users run 4–6 week cycles for both peptides. While there is no established evidence of receptor desensitization for either, cycling with a 2–4 week break is standard practice. For the stack, cycle both off simultaneously.
Ready to start your protocol?
Read the full protocol for either peptide, or use our calculator to get your exact reconstitution and syringe units.